Doctor's Doubts Imperil Lucrative Diabetes Drugs

Friday, 31 May 2013 08:59 AM

  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
An expert in endocrinology and former editor of the journal Diabetes has raised questions about the new drug Januvia, and his research is threatening the future of the lucrative drug and others in the same class that treat type-2 diabetes.

“I knew some stuff that I thought was a worry and I was obliged to pursue it,” Dr. Peter C. Butler, chairman of endocrinology at the University of California, Los Angeles, tells the New York Times.

In his research on the drug developed by Merck, Butler found troublesome changes in the pancreases of rats that could develop into cancer. The results of his follow-up work to that study have prompted investigations by the Food and Drug Administration and the European Medicines Agency that could lead to new label warnings or elimination of the drugs from the market, according to the New York Times.

However, other experts dispute Butler’s claims, saying the data are not conclusive and that the risk, if any, would be quite low.

To read the complete New York Times story, go here.


  Comment  |
   Contact Us  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Retype Email:
Zip Code:
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Pot Smoking Linked to Heart Attacks

Wednesday, 23 Apr 2014 17:33 PM

The number of heart complications attributed to marijuana use increased slightly in France between 2006 and 2010, accord . . .

Scientists Uncover Longevity Secrets of 115-Year-Old Woman

Wednesday, 23 Apr 2014 17:00 PM

More than 400 mutations were found in the healthy white blood cells of a 115-year-old woman, according to a new study th . . .

Jenny Craig Diet Helps Diabetics: Study

Wednesday, 23 Apr 2014 16:54 PM

A commercial diet plan that includes prepackaged foods, menu plans and access to counselors was better at helping people . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved